Thalys Medical Technology Group Corporation (SHA:603716)
China · Delayed Price · Currency is CNY 17.57
+0.46 (2.69%)
Sep 1, 2026, 3:00 PM CST
SHA:603716 Market Cap
SHA:603716 has a market cap or net worth of 3.66 billion as of August 31, 2026. Its market cap has decreased by -42.31% in one year.
Market Cap
3.66B
Enterprise Value
3.76B
Revenue
836.23M
Ranking
n/a
PE Ratio
n/a
Stock Price
17.57
ChartMarket Cap Chart
Since October 31, 2016, SHA:603716's market cap has increased from 1.97B to 3.66B, an increase of 85.59%. That is a compound annual growth rate of 6.49%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 31, 2026 | 3.66B | -13.55% |
| Dec 31, 2025 | 4.24B | 213.84% |
| Dec 31, 2024 | 1.35B | -36.50% |
| Dec 29, 2023 | 2.13B | 0.51% |
| Dec 30, 2022 | 2.12B | -24.46% |
| Dec 31, 2021 | 2.80B | -14.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Oct 31, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Beijing Strong Biotechnologies,Inc. | 6.86B |
| Amoy Diagnostics | 6.85B |
| Shanghai Runda Medical Technology | 5.93B |
| Maccura Biotechnology Co.Ltd | 5.64B |
| Cowealth Medical China | 4.93B |
| Shanghai Labway Clinical Laboratory | 4.45B |
| Guangdong Hybribio Biotech | 3.80B |
| Medicalsystem Biotechnology | 3.60B |